Laurus Labs Q4 profit rises to Rs 279 crore, FY26 revenue up 23%
The company reported robust revenue and profit growth for FY26, supported by strong CDMO performance, improving margins, and expansion across advanced manufacturing platforms
The company reported robust revenue and profit growth for FY26, supported by strong CDMO performance, improving margins, and expansion across advanced manufacturing platforms
Healthcare and consumer wellness leader brings extensive experience in business transformation, commercial strategy and growth leadership to Fertin India
Strong CDMO growth, improved product mix and operational leverage drive profitability expansion
The company’s total income jumped 31% year-on-year to Rs 125.5 crore
The company recorded revenue of Rs. 1,065 crore in the third quarter of FY26
Net profit for the half-year rose to Rs. 410 crore from Rs. 351 crore
During the quarter, construction began on a US$ 10 million bioconjugation cGMP suite at NJ Bio’s Princeton site
The company reported revenue from operations at Rs. 6,573.7 crore, up 6 per cent YoY
Subscribe To Our Newsletter & Stay Updated